Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...
mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback